The production of recombinant antibodies has had a tremendous impact on several
research fields, most prominently in biotechnology, immunology and medicine, enabling …

There is an ongoing debate on how antibodies are being generated, produced and used
(Gray, 2020; Marx, 2020). Or rather, there are two debates, which are not necessarily related …

It is well-recognized that research capability in veterinary species is restricted by a lack of
immunological reagents relative to the extensive toolboxes for small rodent biomedical …

Using the best animal models to study immune responses against specific pathogens or
vaccines can dramatically accelerate our understanding. Veterinary species are well …

Recombinant DNA (rDNA) technology has indeed made tremendous breakthrough in the
discovery of various vaccines or diagnostic antigens. The advent of rDNA technology and its …

The success of inactivated and live-attenuated vaccines has enhanced livestock
productivity, promoted food security, and attenuated the morbidity and mortality of several …

The hybridoma technology for production of monoclonal antibodies circumvents many of the
constraints associated with the use of conventional antisera, and consequently broadens the …

Veterinary research and clinical contributions reach into every aspect of biomedical health
and science: livestock production and food safety; zoonotic diseases, epidemiology, and …

“Regenerative medicine” refers to therapies that aim to restore normal form and function
using the body's own biological machinery, such as stem cells and biologics. The use of …

Veterinary immunology: opportunities and challenges: Trends in Immunology Skip to Main
Content Advertisement Trends in Immunology This journal offers authors two options (open …